Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X6MO
|
||||
Former ID |
DIB013431
|
||||
Drug Name |
Ralitoline
|
||||
Synonyms |
GO-4942; Goe-4942; PD-117818
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Epilepsy [ICD10:G40] | Terminated | [545466] | ||
Company |
Parke-Davis & Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C13H13ClN2O2S
|
||||
Canonical SMILES |
C\1(=C\C(=O)Nc2c(Cl)cccc2C)/N(C(=O)CS1)C
|
||||
CAS Number |
CAS 93738-40-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Modulator | [526758] | |
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.